Compare Be Healthy! Be Happy! zinc Immune Support Lozenges to common cold medicines
Compare Be Healthy! Be Happy! zinc Immune Support Lozenges to Emergen-C, Mucinex, and DayQuil cold remedies
|Products:||Be Healthy! Be Happy!||Emergen-C Super||Mucinex-D||DayQuil Severe|
|Active Ingredients||See below||See below||See below||See below|
|Proven to shorten the duration and severity of the common cold* ,,,,,||Yes||No||No||No|
|Decongestant, cough suppressant, analgesic||No||No||Yes||Yes|
|Ingredients found naturally in nature||Yes||Yes||No – manufactured chemicals||No – manufactured chemicals|
|Increased blood pressure||No||No||Yes||No|
|Be Healthy! Be Happy!||Zinc acetate||Zinc gluconate||Selenium selenite|
|Emergen-C Super||Vitamin C||Vitamin B1, B2, B5||Vitamin B9, B12||Manganese|
*This statement has not been evaluated by the FDA. This product is not intended to diagnose, prevent, cure or treat any disease.
Source (ingredients and side effects): Drugs.com @ www.drugs.com
 Hemilä, H., 2015. The effectiveness of high-dose zinc acetate lozenges on various common cold symptoms: a meta-analysis, BMC Family Practice, 16:24, pp. 1-11.
 Science, M., 2012. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials, CMAJ, 184(10), pp. E551-E561.
 Hemilä, H., 2011. Zinc lozenges may shorten the duration of colds: a systematic review. The Open Respiratory Medicine Journal, 5, pp. 51-58.
 Prasad, A., 2008. Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. The Journal of Infectious Diseases, 197, pp. 795-802.
 Prasad, A., 2000. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate, Annals of Internal Medicine, 133 (4), pp. 245-252.
 Petrus, E., 1998. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Current Therapeutic Research, 59 (9), pp. 594-607.